Your browser doesn't support javascript.
loading
Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening.
Sorop, Oana; Heinonen, Ilkka; van Kranenburg, Matthijs; van de Wouw, Jens; de Beer, Vincent J; Nguyen, Isabel T N; Octavia, Yanti; van Duin, Richard W B; Stam, Kelly; van Geuns, Robert-Jan; Wielopolski, Piotr A; Krestin, Gabriel P; van den Meiracker, Anton H; Verjans, Robin; van Bilsen, Marc; Danser, A H Jan; Paulus, Walter J; Cheng, Caroline; Linke, Wolfgang A; Joles, Jaap A; Verhaar, Marianne C; van der Velden, Jolanda; Merkus, Daphne; Duncker, Dirk J.
  • Sorop O; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Heinonen I; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Kranenburg M; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
  • van de Wouw J; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • de Beer VJ; Department of Radiology, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Nguyen ITN; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Octavia Y; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Duin RWB; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Stam K; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Geuns RJ; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Wielopolski PA; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Krestin GP; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van den Meiracker AH; Department of Radiology, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Verjans R; Department of Radiology, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van Bilsen M; Department of Radiology, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Danser AHJ; Department of Internal Medicine, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Paulus WJ; Department of Cardiology, Maastricht University, Maastricht, The Netherlands.
  • Cheng C; Department of Cardiology, Maastricht University, Maastricht, The Netherlands.
  • Linke WA; Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
  • Joles JA; Department of Internal Medicine, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Verhaar MC; Department of Physiology, Amsterdam Cardiovascular Sciences (ACS), VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
  • van der Velden J; Division of Experimental Cardiology, Department of Cardiology, The Thoraxcentre, Cardiovascular Research School COEUR, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Merkus D; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Duncker DJ; Institute of Physiology II, University of Muenster, Muenster, Germany.
Cardiovasc Res ; 114(7): 954-964, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29432575
ABSTRACT

Aims:

More than 50% of patients with heart failure have preserved ejection fraction characterized by diastolic dysfunction. The prevalance of diastolic dysfunction is higher in females and associates with multiple comorbidities such as hypertension (HT), obesity, hypercholesterolemia (HC), and diabetes mellitus (DM). Although its pathophysiology remains incompletely understood, it has been proposed that these comorbidities induce systemic inflammation, coronary microvascular dysfunction, and oxidative stress, leading to myocardial fibrosis, myocyte stiffening and, ultimately, diastolic dysfunction. Here, we tested this hypothesis in a swine model chronically exposed to three common comorbidities. Methods and

results:

DM (induced by streptozotocin), HC (produced by high fat diet), and HT (resulting from renal artery embolization), were produced in 10 female swine, which were followed for 6 months. Eight female healthy swine on normal pig-chow served as controls. The DM + HC + HT group showed hyperglycemia, HC, hypertriglyceridemia, renal dysfunction and HT, which were associated with systemic inflammation. Myocardial superoxide production was markedly increased, due to increased NOX activity and eNOS uncoupling, and associated with reduced NO production, and impaired coronary small artery endothelium-dependent vasodilation. These abnormalities were accompanied by increased myocardial collagen content, reduced capillary/fiber ratio, and elevated passive cardiomyocyte stiffness, resulting in an increased left ventricular end-diastolic stiffness (measured by pressure-volume catheter) and a trend towards a reduced E/A ratio (measured by cardiac MRI), while ejection fraction was maintained.

Conclusions:

The combination of three common comorbidities leads to systemic inflammation, myocardial oxidative stress, and coronary microvascular dysfunction, which associate with myocardial stiffening and LV diastolic dysfunction with preserved ejection fraction.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Función Ventricular Izquierda / Disfunción Ventricular Izquierda / Circulación Coronaria / Vasos Coronarios / Diabetes Mellitus Experimental / Hipercolesterolemia / Hipertensión Renovascular / Microcirculación / Miocardio Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Función Ventricular Izquierda / Disfunción Ventricular Izquierda / Circulación Coronaria / Vasos Coronarios / Diabetes Mellitus Experimental / Hipercolesterolemia / Hipertensión Renovascular / Microcirculación / Miocardio Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article